These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23796814)

  • 1. Cumulative life course impairment in vitiligo.
    Krüger C; Schallreuter KU
    Curr Probl Dermatol; 2013; 44():102-17. PubMed ID: 23796814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-related behavioral patterns and experiences affect quality of life in children and adolescents with vitiligo.
    Krüger C; Panske A; Schallreuter KU
    Int J Dermatol; 2014 Jan; 53(1):43-50. PubMed ID: 23692406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative life course impairment in other chronic or recurrent dermatologic diseases.
    Ibler KS; Jemec GB
    Curr Probl Dermatol; 2013; 44():130-6. PubMed ID: 23796817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life of patients with vitiligo attending the Regional Dermatology Training Center in Northern Tanzania.
    Kiprono S; Chaula B; Makwaya C; Naafs B; Masenga J
    Int J Dermatol; 2013 Feb; 52(2):191-4. PubMed ID: 23347306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative life course impairment: evidence for psoriasis.
    Mattei PL; Corey KC; Kimball AB
    Curr Probl Dermatol; 2013; 44():82-90. PubMed ID: 23796812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vitiligo on self-reported health-related quality of life.
    Ongenae K; Van Geel N; De Schepper S; Naeyaert JM
    Br J Dermatol; 2005 Jun; 152(6):1165-72. PubMed ID: 15948977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness-to-pay and quality of life in patients with vitiligo.
    Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
    Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage.
    Ongenae K; Dierckxsens L; Brochez L; van Geel N; Naeyaert JM
    Dermatology; 2005; 210(4):279-85. PubMed ID: 15942213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life impairment in children and adolescents with vitiligo.
    Silverberg JI; Silverberg NB
    Pediatr Dermatol; 2014; 31(3):309-18. PubMed ID: 24304125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stigmatization experience, coping and sense of coherence in vitiligo patients.
    Schmid-Ott G; Künsebeck HW; Jecht E; Shimshoni R; Lazaroff I; Schallmayer S; Calliess IT; Malewski P; Lamprecht F; Götz A
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):456-61. PubMed ID: 17373970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics.
    Nicolaidou E; Antoniou C; Miniati A; Lagogianni E; Matekovits A; Stratigos A; Katsambas A
    J Am Acad Dermatol; 2012 Jun; 66(6):954-8. PubMed ID: 21982634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of categories at risk for high quality of life impairment in patients with vitiligo.
    Sampogna F; Raskovic D; Guerra L; Pedicelli C; Tabolli S; Leoni L; Alessandroni L; Abeni D
    Br J Dermatol; 2008 Aug; 159(2):351-9. PubMed ID: 18565189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The psychosocial impact of vitiligo in Indian patients.
    Pahwa P; Mehta M; Khaitan BK; Sharma VK; Ramam M
    Indian J Dermatol Venereol Leprol; 2013; 79(5):679-85. PubMed ID: 23974584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative life course impairment: identifying patients at risk.
    Augustin M
    Curr Probl Dermatol; 2013; 44():74-81. PubMed ID: 23796811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant immediate and long-term improvement in quality of life and disease coping in patients with vitiligo after group climatotherapy at the Dead Sea.
    Krüger C; Smythe JW; Spencer JD; Hasse S; Panske A; Chiuchiarelli G; Schallreuter KU
    Acta Derm Venereol; 2011 Mar; 91(2):152-9. PubMed ID: 21240455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life and emotional state in vitiligo in an Estonian sample: comparison with psoriasis and healthy controls.
    Karelson M; Silm H; Kingo K
    Acta Derm Venereol; 2013 Jul; 93(4):446-50. PubMed ID: 23306792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and psychological adaptation of Korean adolescents with vitiligo.
    Choi S; Kim DY; Whang SH; Lee JH; Hann SK; Shin YJ
    J Eur Acad Dermatol Venereol; 2010 May; 24(5):524-9. PubMed ID: 19807826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To what extent is quality of life impaired in vitiligo? A multicenter study on Italian patients using the dermatology life quality index.
    Ingordo V; Cazzaniga S; Medri M; Raone B; Digiuseppe MD; Musumeci ML; Romano I; Fai D; Pellegrino M; Pezzarossa E; Di Lernia V; Peccerillo F; Battarra VC; Sirna R; Patrizi A; Naldi L
    Dermatology; 2014; 229(3):240-7. PubMed ID: 25358871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of depression in vitiligo patients.
    Al-Harbi M
    Skinmed; 2013; 11(6):327-30. PubMed ID: 24517036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The burden of vitiligo: patient characteristics associated with quality of life.
    Linthorst Homan MW; Spuls PI; de Korte J; Bos JD; Sprangers MA; van der Veen JP
    J Am Acad Dermatol; 2009 Sep; 61(3):411-20. PubMed ID: 19577331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.